State Street’s Latigo Biotherapeutics LTGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$396K Buy
+23,700
New +$500K ﹤0.01% 3722

Other funds holding LTGO

State Street's LTGO Position: Q3 2026 in Review

State Street opened a new position in Latigo Biotherapeutics (LTGO) in Q3 2026: 23,700 shares worth $396K. The stake represents ﹤0.01% of the portfolio and ranks #3722 among its holdings.

58 funds tracked by Wall St. Rank hold LTGO as of Q3 2026.

  • State Street held 23,700 shares of Latigo Biotherapeutics worth $396K as of Q3 2026.
  • Latigo Biotherapeutics was a new State Street position in Q3 2026.
  • Latigo Biotherapeutics made up ﹤0.01% of State Street's portfolio in Q3 2026, its #3722 holding.
  • 58 funds tracked by Wall St. Rank held Latigo Biotherapeutics as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.